BioInvent International (Sweden) Probability of Future Stock Price Finishing Over 49.01

BINV Stock  SEK 44.55  1.20  2.62%   
BioInvent International's future price is the expected price of BioInvent International instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of BioInvent International AB performance during a given time horizon utilizing its historical volatility. Check out BioInvent International Backtesting, BioInvent International Valuation, BioInvent International Correlation, BioInvent International Hype Analysis, BioInvent International Volatility, BioInvent International History as well as BioInvent International Performance.
  
Please specify BioInvent International's target price for which you would like BioInvent International odds to be computed.

BioInvent International Target Price Odds to finish over 49.01

The tendency of BioInvent Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over kr 49.01  or more in 90 days
 44.55 90 days 49.01 
about 5.2
Based on a normal probability distribution, the odds of BioInvent International to move over kr 49.01  or more in 90 days from now is about 5.2 (This BioInvent International AB probability density function shows the probability of BioInvent Stock to fall within a particular range of prices over 90 days) . Probability of BioInvent International price to stay between its current price of kr 44.55  and kr 49.01  at the end of the 90-day period is about 37.94 .
Assuming the 90 days trading horizon the stock has the beta coefficient of 1.47 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, BioInvent International will likely underperform. Additionally BioInvent International AB has an alpha of 0.0639, implying that it can generate a 0.0639 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   BioInvent International Price Density   
       Price  

Predictive Modules for BioInvent International

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as BioInvent International. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
40.5644.5548.54
Details
Intrinsic
Valuation
LowRealHigh
33.6337.6249.01
Details
Naive
Forecast
LowNextHigh
37.3741.3645.36
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
43.8244.9546.08
Details

BioInvent International Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. BioInvent International is not an exception. The market had few large corrections towards the BioInvent International's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold BioInvent International AB, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of BioInvent International within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.06
β
Beta against Dow Jones1.47
σ
Overall volatility
3.07
Ir
Information ratio 0.03

BioInvent International Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of BioInvent International for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for BioInvent International can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
BioInvent International had very high historical volatility over the last 90 days
The company reported the revenue of 19.38 M. Net Loss for the year was (278.44 M) with profit before overhead, payroll, taxes, and interest of 19.38 M.
BioInvent International AB has accumulated about 28.46 M in cash with (245.84 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.08.
Roughly 57.0% of the company shares are held by institutions such as insurance companies

BioInvent International Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of BioInvent Stock often depends not only on the future outlook of the current and potential BioInvent International's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. BioInvent International's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding107.5 M
Cash And Short Term Investments1.1 B

BioInvent International Technical Analysis

BioInvent International's future price can be derived by breaking down and analyzing its technical indicators over time. BioInvent Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of BioInvent International AB. In general, you should focus on analyzing BioInvent Stock price patterns and their correlations with different microeconomic environments and drivers.

BioInvent International Predictive Forecast Models

BioInvent International's time-series forecasting models is one of many BioInvent International's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary BioInvent International's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about BioInvent International

Checking the ongoing alerts about BioInvent International for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for BioInvent International help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
BioInvent International had very high historical volatility over the last 90 days
The company reported the revenue of 19.38 M. Net Loss for the year was (278.44 M) with profit before overhead, payroll, taxes, and interest of 19.38 M.
BioInvent International AB has accumulated about 28.46 M in cash with (245.84 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.08.
Roughly 57.0% of the company shares are held by institutions such as insurance companies

Additional Tools for BioInvent Stock Analysis

When running BioInvent International's price analysis, check to measure BioInvent International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioInvent International is operating at the current time. Most of BioInvent International's value examination focuses on studying past and present price action to predict the probability of BioInvent International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioInvent International's price. Additionally, you may evaluate how the addition of BioInvent International to your portfolios can decrease your overall portfolio volatility.